| Dr Melissa Ann Meyer, DO | |
|
8105 Adams Dr Ste C, Hummelstown, PA 17036-8625 | |
| (717) 988-9002 | |
| (717) 221-5375 |
| Full Name | Dr Melissa Ann Meyer |
|---|---|
| Gender | Female |
| Speciality | Orthopaedic Surgery |
| Location | 8105 Adams Dr Ste C, Hummelstown, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174978951 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 2021024770 (Missouri) | Secondary |
| 207X00000X | Orthopaedic Surgery | OS022387 (Pennsylvania) | Primary |
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
If one wants to better understand how plants grow, one must analyse the chemistry of life in its molecular detail. Michael Hothorn from the Friedrich-Miescher-Laboratory of the Max Planck Society in T-bingen and his team are doing just that. Their latest work now reveals that a plant membrane receptor requires a helper protein to sense a growth-promoting steroid hormone and to transduce this signal across the cell membrane.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it expects revenue for the fourth quarter ended December 31, 2010 to exceed $14.2 million. Revenues for the full year were approximately $55 million, a 7% increase over 2009 revenues, driven by an increase of approximately 10% in revenues from the core ICL and IOL product lines.
Even a minor surgery such as a laparoscopic gallbladder removal can prove to be a high-risk and even fatal procedure for frail patients, according to new research published in JAMA Surgery.
NPS Pharmaceuticals, Inc. today announced that it has priced an underwritten public offering of 9,000,000 shares of its common stock at a price to the public of $5.50 per share. Net proceeds, after estimated underwriting discounts and commissions and estimated expenses, will be approximately $46.2 million.
Researchers have discovered a novel mechanism by which biguanides exert their glucose-lowering effect, potentially leading to new therapeutic approaches to the treatment of diabetes and insulin resistance.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa Ann Meyer, DO 8105 Adams Dr Ste C, Hummelstown, PA 17036-8625 Ph: (717) 988-9002 | Dr Melissa Ann Meyer, DO 8105 Adams Dr Ste C, Hummelstown, PA 17036-8625 Ph: (717) 988-9002 |
News Archive
If one wants to better understand how plants grow, one must analyse the chemistry of life in its molecular detail. Michael Hothorn from the Friedrich-Miescher-Laboratory of the Max Planck Society in T-bingen and his team are doing just that. Their latest work now reveals that a plant membrane receptor requires a helper protein to sense a growth-promoting steroid hormone and to transduce this signal across the cell membrane.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it expects revenue for the fourth quarter ended December 31, 2010 to exceed $14.2 million. Revenues for the full year were approximately $55 million, a 7% increase over 2009 revenues, driven by an increase of approximately 10% in revenues from the core ICL and IOL product lines.
Even a minor surgery such as a laparoscopic gallbladder removal can prove to be a high-risk and even fatal procedure for frail patients, according to new research published in JAMA Surgery.
NPS Pharmaceuticals, Inc. today announced that it has priced an underwritten public offering of 9,000,000 shares of its common stock at a price to the public of $5.50 per share. Net proceeds, after estimated underwriting discounts and commissions and estimated expenses, will be approximately $46.2 million.
Researchers have discovered a novel mechanism by which biguanides exert their glucose-lowering effect, potentially leading to new therapeutic approaches to the treatment of diabetes and insulin resistance.
› Verified 8 days ago
Dr. Naveed Nabizadeh, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 8105 Adams Dr Ste C, Hummelstown, PA 17036 Phone: 717-988-9032 Fax: 717-221-5375 | |
Vagmin P Vora, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1842 Gramercy Pl, Hummelstown, PA 17036 Phone: 717-712-2142 |